Commercial Insurance for Pharmacies and Drug Stores

Not writing pharmacy malpractice for compounding pharmacies at standard dispensing rates

Compounding pharmacies face substantially higher professional liability exposure than standard retail dispensing pharmacies. A compounding pharmacy that sterile-compounds injectable medications, IV solutions, ophthalmologic preparations, or other sterile products operates under USP 797 requirements and has exposure to contamination, potency errors, and sterility failures that can injure multiple patients from a single batch. The 2012 New England Compounding Center meningitis outbreak that caused 64 deaths and 751 illnesses from contaminated methylprednisolone injections is the benchmark for compounding pharmacy liability severity. Compounding pharmacies must be rated as compounding operations — not standard dispensing — and require specialty markets with compounding pharmacy experience.

Undervaluing drug inventory by using average rather than peak inventory value

Pharmacy drug inventory fluctuates with seasonal demand (flu vaccines, allergy medications, cold and flu season), specialty drug patient enrollment cycles, and controlled substance inventory management practices. A retail pharmacy that averages $300,000 in drug inventory may carry $500,000–$600,000 at peak times. The property policy insured inventory value must reflect the peak, not the average — because a total loss from a fire or a large-scale robbery that clears the controlled substance cabinet is equally likely during a high-inventory period as a low-inventory period. Specialty pharmacies that maintain expensive biologic medications (adalimumab, ustekinumab, specialty oncology agents) may have single-drug inventory values that exceed the entire inventory value of a standard retail pharmacy.

Not asking about immunization services and the product liability exposure from vaccine administration

Most retail pharmacies now offer immunization services — flu shots, COVID vaccines, shingles vaccines, travel vaccines, and other routine immunizations administered by pharmacists. Vaccine administration creates a product liability and professional liability exposure that goes beyond standard dispensing. A vaccine administration error (wrong vaccine, wrong dose, improper injection technique that causes nerve damage, or anaphylaxis from a vaccine given to a patient with an undisclosed allergy) creates a claim that may sit in the grey zone between professional liability (pharmacist error) and GL (premises injury). The professional liability policy must specifically include immunization services as a covered professional activity.

Missing crime coverage limits adequate for controlled substance robbery exposure

Pharmacy robbery involving controlled substances is a distinct and serious crime category. Armed pharmacy robberies targeting opioid medications — oxycodone, hydrocodone, fentanyl — are reported across the country, with single robbery events removing thousands of dosage units of Schedule II controlled substances. The crime coverage limits must reflect the controlled substance inventory value, which in a high-volume pharmacy may be $50,000–$200,000 in Schedule II medications alone. Standard commercial crime limits of $25,000–$50,000 are inadequate for pharmacies with significant controlled substance inventory.